Plant Health Care PLC
LSE:PHC
Plant Health Care PLC
Cash & Cash Equivalents
Plant Health Care PLC
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Plant Health Care PLC
LSE:PHC
|
Cash & Cash Equivalents
$5.7m
|
CAGR 3-Years
54%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-8%
|
|
CF Industries Holdings Inc
NYSE:CF
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
23%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-8%
|
|
FMC Corp
NYSE:FMC
|
Cash & Cash Equivalents
$417.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
Corteva Inc
NYSE:CTVA
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Scotts Miracle-Gro Co
NYSE:SMG
|
Cash & Cash Equivalents
$65.1m
|
CAGR 3-Years
65%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-8%
|
|
Mosaic Co
NYSE:MOS
|
Cash & Cash Equivalents
$336.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-18%
|
See Also
What is Plant Health Care PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
5.7m
USD
Based on the financial report for Jun 30, 2023, Plant Health Care PLC's Cash & Cash Equivalents amounts to 5.7m USD.
What is Plant Health Care PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-8%
Over the last year, the Cash & Cash Equivalents growth was 192%. The average annual Cash & Cash Equivalents growth rates for Plant Health Care PLC have been 54% over the past three years , 17% over the past five years , and -8% over the past ten years .